Alignment Healthcare (ALHC) just had a big breakout and looks ready to run even higher. Here’s what’s going on…

The Catalyst Behind The Breakout

Alignment Healthcare is a Medicare Advantage-focused health insurance and value-based care company. In simple terms, it works with seniors through Medicare Advantage plans and aims to improve outcomes while managing costs more efficiently.

That matters because on April 7, the Centers for Medicare & Medicaid Services (CMS) finalized its 2027 Medicare Advantage and Part D payment policies, which CMS said are projected to result in a net average increase of 2.48% in MA payments — or more than $13 billion in additional payments to plans. Since Alignment’s business is heavily tied to Medicare Advantage, that rate hike directly improves the company’s economics.

The market reacted immediately. The stock gapped from roughly $18.67 to $21.66 in a single session — a gain of about 16% — as investors rushed back into the name. And it wasn’t an isolated move. Other Medicare Advantage-related stocks also jumped on the news, confirming that this was a real sector catalyst, not just random buying.

From a technical standpoint, that policy-driven gap higher has now pushed ALHC into a much more bullish chart position. The stock has broken out with strong volume, reclaimed key moving averages, and now appears to be building momentum for a possible continuation move higher.

Smart Money Was Already There

What makes the setup even more interesting is that institutional investors appear to have been positioning ahead of the catalyst. Recent 13F and 13G filings released in January and February showed that several large institutions had already built or increased positions in ALHC ahead of the April CMS catalyst, including Fidelity, Invesco, Vanguard, and Northwestern Mutual, suggesting that larger, longer-term funds were already building exposure before the CMS announcement hit.

Date* Fund Shares Bought $ Amount
29 Jan Vanguard 1.5M $30.1M
02 Feb Danica Pension 2.0M $39.5M
05 Feb Northwestern Mutual 691.6K $13.7M
10 Feb Acadian Asset Mgmt 967.6K $19.1M
10 Feb Bank of NY Mellon 538.1K $10.6M
10 Feb Jupiter Asset Mgmt 555.1K $11.0M
11 Feb Capital World Investors 2.2M $44.2M
12 Feb Loomis Sayles 2.2M $44.2M
13 Feb Caxton Associates 259.4K $5.1M
17 Feb FMR LLC (Fidelity) 6.6M $129.9M
17 Feb Oberweis 747.5K $14.8M
17 Feb Integral Health AM 600.0K $11.8M
17 Feb ExodusPoint 381.2K $7.5M
19 Feb Invesco 1.7M $34.3M

If needed, swipe or scroll sideways to view the full table. *This is the SEC filing/reporting date, not the actual purchase date.

That doesn’t guarantee the stock moves straight up from here, of course. After such a sharp gap, the key question is whether ALHC can hold the breakout and build on it — or whether shares first pull back to digest the move.

But right now, the combination of a clear fundamental catalyst, strong institutional buying ahead of the catalyst, and a bullish technical breakout makes this one of the more interesting setups on the board.

The policy catalyst may have sparked the move, but the technical setup is what could help sustain it. Here are the bullish technical signals on the chart that traders should be watching now.

Bullish Technical Signals

#1 Symmetrical Triangle Pattern Breakout: The daily chart shows that the stock has recently formed a Symmetrical Triangle pattern. This is a continuation pattern and is characterized by two converging trend lines connecting a series of sequential peaks and troughs. This pattern is marked on the daily chart as purple lines. The breakout from a symmetrical triangle pattern usually signifies a bullish move. Currently, the stock has broken out of the symmetrical triangle pattern with high volume, which is a possible bullish sign.

ALHC – Daily Chart

#2 Price above MAs: The price is currently above the short-term moving average of 50-day SMA as well as the longer-term moving average of 200-day SMA, indicating that the bulls are still in control. This is a positive indication.

#3 MACD Above Signal Line: In the daily chart, the MACD line (light blue color) is currently above the MACD signal line (orange color), which is typically considered bullish.

#4 Bullish ADX: The ADX indicator shows that the +DI line is currently above the –DI line, and the ADX line has started to move up from below the –DI and +DI lines. This indicates possible bullishness.

#5 Above Support Area: As you can see from the weekly chart, the stock has currently moved up from a resistance-turned-support level. This level is marked as a pink dotted line. This looks like a good area for the stock to move higher. The stock is also trading above its 50-week and 200-week SMA, indicating that the bulls are still in control.

ALHC – Weekly Chart

#6 %K above %D: The %K (blue) line of stochastic has currently crossed above the %D (Orange) line in the weekly chart and is also moving higher from oversold levels. This is a possible bullish indication.

#7 Bullish RSI: In the weekly chart, the RSI is currently nearing 50 and moving higher. This is a possible bullish sign.

Recommended Trade (based on the charts)

Buy Levels: If you want to get in on this trade, you can purchase shares of ALHC above the price of around $21.80.

TP: Our target prices are $25.00 and $28.00 in the next 3-6 months.

SL: To limit risk, place a stop-loss at $19.90. Note that the stop-loss is on a closing basis.

Our target potential upside is 15% to 28% in the next 3 to 6 months.

For a risk of $1.90, our target rewards are $3.20 and $6.20. This is a nearly 1:2 and 1:3 risk-reward trade.

In other words, this trade offers nearly 2x to 3x more potential upside than downside.

Risks to Consider
The stock may reverse its overall trend if it breaks down from the symmetrical triangle pattern with high volume. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in the sector.

Happy Trading!

Tara

Investors Can't Afford to Miss This [sponsor]
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.